Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pias Corporation currently has 1 pending office action. This action is being reviewed by 1 distinct examiner, KIM, SEONG JONG. There are 0 distinct art units listed for this company's pending activity, which may reflect the current administrative status of the application.
KIM, SEONG JONG is the busiest examiner with 1 busiest examiner pending action. Since the company has only 1 pending office action in total, this examiner is the sole point of contact for the company's active patent matters. Practitioners should tailor their approach to the specific examination style of KIM, SEONG JONG to navigate the prosecution process.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18851716 | Atopic Dermatitis Improving Agent, Interleukin Production Inhibitor, and Inhibitor of Expression of Interleukin Gene | KIM, SEONG JONG | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18851716 | Atopic Dermatitis Improving Agent, Interleukin Production Inhibitor, and Inhibitor of Expression of Interleukin Gene | KIM, SEONG JONG | — | §102§103§112 | Non-Final OA | — | Pending | Sep 27, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial